Charles River Laboratories International (CRL) Long-Term Debt Issuances: 2009-2025
Historic Long-Term Debt Issuances for Charles River Laboratories International (CRL) over the last 16 years, with Sep 2025 value amounting to $107.5 million.
- Charles River Laboratories International's Long-Term Debt Issuances fell 54.37% to $107.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 17.21%. This contributed to the annual value of $1.1 billion for FY2024, which is 39.32% up from last year.
- Latest data reveals that Charles River Laboratories International reported Long-Term Debt Issuances of $107.5 million as of Q3 2025, which was down 80.35% from $547.0 million recorded in Q2 2025.
- In the past 5 years, Charles River Laboratories International's Long-Term Debt Issuances registered a high of $3.0 billion during Q2 2021, and its lowest value of $51.2 million during Q3 2023.
- Its 3-year average for Long-Term Debt Issuances is $266.3 million, with a median of $235.6 million in 2024.
- As far as peak fluctuations go, Charles River Laboratories International's Long-Term Debt Issuances spiked by 111,972,800.00% in 2021, and later plummeted by 92.67% in 2023.
- Quarterly analysis of 5 years shows Charles River Laboratories International's Long-Term Debt Issuances stood at $831.4 million in 2021, then slumped by 81.51% to $153.8 million in 2022, then surged by 188.31% to $443.3 million in 2023, then plummeted by 76.36% to $104.8 million in 2024, then slumped by 54.37% to $107.5 million in 2025.
- Its Long-Term Debt Issuances stands at $107.5 million for Q3 2025, versus $547.0 million for Q2 2025 and $416.3 million for Q1 2025.